ArticlePloS one2021

Comparison of the clinical impact of 2-[18F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer's disease.

Le Gjerum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.